Profile
Sector:
HealthcareIndustry:
Pharmaceutical RetailersCountry:
United StatesIPO:
06 February 2014Website:
http://www.trxadehealth.comNext earnings report:
08 July 2024Last dividends:
25 March 2024Next dividends:
N/APrice
after hours | Wed, 03 Jul 2024 20:46:25 GMTAnalysts recommendations
Institutional Ownership
MEDS Latest News
Trxade Health (NASDAQ: MEDS ) stock is soaring higher on Tuesday after the U.S. health services IT company announced a major asset sale. According to a filing with the Securities and Exchange Commission (SEC), wholly-owned subsidiary Trxade, Inc. is going to sell virtually all of its assets to Micro Merchant Systems.
TAMPA, FL / ACCESSWIRE / July 31, 2023 / TRxADE HEALTH INC. (NASDAQ:MEDS), is a health services IT company focused on digitalizing the retail pharmacy experience by optimizing drug procurement, the prescription journey and patient engagement in the U.S., will release financial results for the second quarter 2023, after market close on August 14, 2023.
Trxade Health (NASDAQ: MEDS ) stock is falling on Tuesday after the company announced it would undergo a merger with Superlatus . That merger will see Trxade Health distribute 3,839,176 shares of MEDS stock to current shareholders in Superlatus.
One of the biggest movers in today's market is little-known health tech company TRxADE Health (NASDAQ: MEDS ). Shares of MEDS stock have rocketed more than 60% higher as of this writing on an otherwise uneventful day in the market.
TRxADE HEALTH, Inc. (NASDAQ:MEDS ) Q1 2023 Earnings Conference Call May 15, 2023 6:00 PM ET Company Participants Prashant Patel - Interim Chief Financial Officer Suren Ajjarapu - Founder, Chairman and Chief Executive Officer Conference Call Participants Allen Klee - Maxim Group LLC Howard Halpern - Taglich Brothers, LLC Operator Good afternoon, ladies and gentlemen. Thank you for standing by.
TRxADE (MEDS) came out with a quarterly loss of $0.03 per share versus the Zacks Consensus Estimate of a loss of $0.02. This compares to loss of $0.12 per share a year ago.
TAMPA, FL / ACCESSWIRE / May 5, 2023 / TRxADE HEALTH INC. (NASDAQ:MEDS) , is a health services IT company focused on digitalizing the retail pharmacy experience by optimizing drug procurement, the prescription journey and patient engagement in the U.S., will release financial results for the first quarter 2023, after market close on May 15, 2023.
TAMPA, FL / ACCESSWIRE / April 25, 2023 / TRxADE HEALTH INC. (NASDAQ:MEDS), is a health services IT company focused on digitalizing the retail pharmacy experience by optimizing drug procurement, the prescription journey and patient engagement in the U.S., will release financial results for the first quarter 2023, after market close on May 8, 2023.
TRxADE HEALTH, Inc. (NASDAQ:MEDS ) Q4 2022 Earnings Conference Call March 27, 2023 5:30 PM ET Company Participants Prashant Patel - CFO Surendra Ajjarapu - Founder, Chairman and CEO Conference Call Participants Allen Klee - Maxim Group Howard Halpern - Taglich Brothers Operator Good afternoon, ladies and gentlemen. Thank you for standing by.
TRxADE (MEDS) delivered earnings and revenue surprises of -66.67% and 8.54%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
What type of business is TRxADE HEALTH?
TRxADE HEALTH, Inc. operates as a health services IT company in the United States. The company focuses on digitalizing the retail pharmacy experience by optimizing drug procurement, prescription journey, and patient engagement. It operates the TRxADE drug procurement marketplace, which fosters price transparency and serves approximately 11,800 members; and offers patient centric telehealth services under the Bonum Health brand name. The company was formerly known as Trxade Group, Inc. and changed its name to TRxADE HEALTH, Inc. in June 2021. TRxADE HEALTH, Inc. is based in Land O' Lakes, Florida.
What sector is TRxADE HEALTH in?
TRxADE HEALTH is in the Healthcare sector
What industry is TRxADE HEALTH in?
TRxADE HEALTH is in the Pharmaceutical Retailers industry
What country is TRxADE HEALTH from?
TRxADE HEALTH is headquartered in United States
When did TRxADE HEALTH go public?
TRxADE HEALTH initial public offering (IPO) was on 06 February 2014
What is TRxADE HEALTH website?
https://www.trxadehealth.com
Is TRxADE HEALTH in the S&P 500?
No, TRxADE HEALTH is not included in the S&P 500 index
Is TRxADE HEALTH in the NASDAQ 100?
No, TRxADE HEALTH is not included in the NASDAQ 100 index
Is TRxADE HEALTH in the Dow Jones?
No, TRxADE HEALTH is not included in the Dow Jones index
When does TRxADE HEALTH report earnings?
The next expected earnings date for TRxADE HEALTH is 08 July 2024